NCT06010251

Brief Summary

The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Oct 2023Oct 2026

First Submitted

Initial submission to the registry

August 18, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 24, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 17, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2026

Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

August 18, 2023

Last Update Submit

November 19, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in neuropathic pain severity assessed by Neuropathic Pain Symptom Inventory (NPSI)

    The NPSI is a self-reported, validated questionnaire that includes 10 items (on different pain sensations, e.g., burning, squeezing, electric-shock, etc.) used to evaluate the properties of neuropathic pain. Each item is scored on an 11-point NRS (0 meaning no symptom and 10 meaning worst symptom), with higher scores indicating more severe neuropathic pain symptoms.

    Baseline, up to 4 weeks

  • Change in neuropathic pain interference assessed by pain interference questionnaire.

    The questionnaire consists in a numerical rating of pain interference ranging from 0= No Interference to 10=Extreme interference with activities, mood and sleep

    Baseline, up to 4 weeks

  • Changes associated with sensory function/dysfunction assessed by quantitative sensory testing

    The sensory test assesses thermal thresholds and includes: cool detection threshold (CDT), warm detection threshold (WDT), cold pain threshold (CPT), hot pain threshold (HPT), all performed using the method of limits: 0 to 50 Celsius (ºC) all values will be reported in Celsius.

    Baseline, up to 4 weeks

Secondary Outcomes (3)

  • Change in manageable pain assessed by days of manageable pain questionnaire.

    Baseline, up to 4 weeks

  • Changes of psychosocial assessed by Multidimensional Pain Inventory (pain severity subscale)

    Baseline, up to 4 weeks

  • Change in Global impression of changes by PGIC questionnaire

    Baseline, up to 4 weeks

Study Arms (1)

SCI with pain

EXPERIMENTAL

Participants will undergo 2-4 weeks of combined intervention including transcranial direct current stimulation (tDCS) and bodily illusions (10 sessions total).

Other: tDCS and bodily illusions

Interventions

Participants will be required to perform (in person) 10 interventions over a time frame of 2-4 weeks. They can perform this everyday or for a minimum of 2-3 times per week over 4 weeks. Two types of illusions will be used 15 min each, the rubber hand illusion and the walking illusion to target upper and lower limbs. These procedures will impact the body representation of the participants resulting in bodily illusions.

SCI with pain

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SCI with Pain:
  • Men or women
  • fluent in English
  • years of age who have: (3a) Complete and incomplete SCI, level of injury (above L1); (3b) Persistent neuropathic pain started after the injury for a minimum of three months prior to entering the study that is at least moderate in severity, defined as ≥ 4 on a Numeric Rating Scale (NRS) ranging 0 to 10.

You may not qualify if:

  • Participants will be excluded if they have:
  • Major psychiatric disease/disorder (self-reported);
  • a significant neurological trauma (self-reported) other than SCI;
  • a recent (one-year) history of alcohol or drug abuse assessed by the Drug Abuse Screening Test (DAST-10)
  • history of visual and hearing loss not corrected
  • history of epilepsy or seizures
  • any metal implants in the head, or implanted devices such as cochlea implants or cardiac pacemakers.
  • We will not include any special population like:
  • Adults unable to consent Individuals who are not yet adults (infants, children, teenagers) Pregnant women Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesNeuralgia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPeripheral Nervous System DiseasesNeuromuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Eva Widerstrom-Noga, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eva Widerstrom-Noga, PhD

CONTACT

Roberta Vastano, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 18, 2023

First Posted

August 24, 2023

Study Start

October 17, 2023

Primary Completion (Estimated)

October 20, 2026

Study Completion (Estimated)

October 20, 2026

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations